Andrew I. Koven's most recent trade in MetaVia Inc. was a trade of 28,147 Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MetaVia Inc. | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 28,147 | 45,699 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2025 | 6,850 | 6,850 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2025 | 3,050 | 16,972 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 3,900 | 3,900 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 1,750 | 13,922 (0%) | 0% | 0 | Common Stock | |
| MetaVia Inc. | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 5,051 | 17,552 (0%) | 0% | 0 | Common Stock | |
| MetaVia Inc. | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2023 | 87,500 | 87,500 (0%) | 0% | 0 | Common Stock | |
| MetaVia Inc. | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2023 | 12,500 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| MetaVia Inc. | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| MetaVia Inc. | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,000 | 60,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Andrew I. Koven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 25,000 | 53,000 (0%) | 0% | 0 | Common Stock |